- The study addressed poorly defined risk factors for recurrent or bilateral facial palsy in Bell's Palsy or Ramsay Hunt Syndrome.
- This retrospective study included 440 patients with facial palsy, comparing recurrent and bilateral cases to nonrecurrent unilateral cases.
- Age under 40 at onset was associated with recurrence (p = 0.017), and autoimmune disease with bilaterality (p = 0.030).
- The authors concluded that younger age and autoimmune disease are specific risk factors for recurrent and bilateral facial palsy, respectively.
- Clinicians should consider these factors when assessing patients with Bell's Palsy or Ramsay Hunt Syndrome for recurrence risk.
Navigating the Complexities of Facial Palsy Recurrence and Bilaterality
Acute facial palsy, most commonly idiopathic Bell's Palsy or varicella zoster-related Ramsay Hunt Syndrome, typically presents as a unilateral, nonrecurrent event [1, 2]. While often self-limiting, the condition's impact on speech, eating, and eye protection requires careful management and exclusion of other causes like Lyme disease or central nervous system infections [3, 4, 5]. However, a subset of patients experiences recurrent episodes or bilateral involvement, creating significant clinical uncertainty and patient distress [2]. A clear understanding of the predisposing factors for these more complex presentations is essential for accurate prognostication and patient counseling [6].
Understanding the Study Design and Patient Cohort
To clarify the poorly defined risk factors for atypical facial palsy, investigators conducted a retrospective analysis of patients diagnosed with Bell's palsy or Ramsay Hunt syndrome between 2009 and 2025. The study aimed to identify predictors for recurrence and bilaterality. From an initial group of 1,108 patients, the final analysis included 440 individuals. The researchers carefully excluded patients with alternative etiologies for their recurrent palsy to ensure the findings were specific to Bell's palsy and Ramsay Hunt syndrome, thus reducing potential confounding variables. The primary outcome was the identification of risk factors by comparing recurrent and bilateral cohorts to a control group of patients with nonrecurrent, unilateral facial palsy. As a secondary outcome, the severity of paralysis was objectively measured using the Facial Nerve Clinician-Graded Scale (eFACE), a standardized instrument for evaluating facial nerve function.
Identifying Key Risk Factors for Recurrence and Bilaterality
The analysis of the 440-patient cohort established a clear prevalence for these less common presentations. The study found that 30 patients (6.8%) experienced a recurrent episode of facial palsy, while 32 patients (7.3%) had a bilateral presentation. Delving into predictive factors, the researchers identified two statistically significant associations. Age under 40 at the initial onset of facial palsy was associated with a greater likelihood of recurrence (p = 0.017). This finding suggests that younger patients may warrant specific counseling about the potential for future episodes. Separately, the presence of a pre-existing autoimmune disease was associated with bilateral facial palsy (p = 0.030). This connection underscores the importance of a thorough systemic history, as bilateral presentation may be a marker for underlying systemic inflammation.
Severity and Etiology: Similar Outcomes Despite Differences
A clinically significant finding from the study relates to the severity of these events. Despite the distress that recurrent or bilateral episodes can cause, the investigation found that the severity of facial palsy did not differ between the recurrent (p = 0.583) or bilateral (p = 0.205) groups when compared with the standard nonrecurrent, unilateral group. This suggests that clinicians and patients should not necessarily anticipate a more severe course of paralysis in these subsequent or bilateral events. Furthermore, the study compared outcomes between the two primary etiologies, revealing no significant differences. Patients with Bell’s palsy and Ramsay Hunt syndrome had similar rates of recurrence (p = 0.922), bilaterality (p = 0.403), and overall palsy severity (p = 0.169). For patients who did experience recurrence, the study noted that the events tended to occur approximately one decade apart, providing a useful timeframe for long-term patient education.
Clinical Implications for Patient Management
These findings provide practicing physicians with specific data to refine patient counseling. For a patient presenting with a first episode of Bell's palsy or Ramsay Hunt syndrome, knowing that age under 40 is a risk factor for recurrence allows for a more nuanced prognostic discussion. Similarly, when a patient presents with bilateral facial palsy, the association with autoimmune disease should prompt a focused review of their medical history and systems for related conditions. This information helps set realistic expectations and may guide further clinical inquiry.
Perhaps most importantly, the study offers data for patient reassurance. The finding that recurrent or bilateral episodes are not associated with increased severity can help alleviate patient anxiety about their prognosis. Clinicians can confidently state that a subsequent event is not expected to be functionally worse than a primary, unilateral episode. The similar outcomes between Bell's palsy and Ramsay Hunt syndrome in terms of recurrence, bilaterality, and severity also simplify the prognostic conversation. Finally, noting that recurrences tend to happen about a decade apart helps frame the long-term outlook for the small subset of patients who may face another episode in the future.
References
1. Liu Y, Yang L, Xue Z, Zhou S. Association between hypertensive disorders and Bell’s palsy in pregnancy: protocol for a systematic review and meta-analysis. BMJ Open. 2024. doi:10.1136/bmjopen-2023-080322
2. Johansen CF, Bhatia SS, Patel DR, White-Dzuro CG, Lee M, Rozen SM. Recurrent and Bilateral Facial Palsy in Bell's Palsy and Ramsay-Hunt Syndrome: Risk Factors and Clinical Outcomes.. Plastic and reconstructive surgery. 2026. doi:10.1097/PRS.0000000000013182
3. Starnoni D, Giammattei L, Cossu G, et al. Surgical management for large vestibular schwannomas: a systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section. Acta Neurochirurgica. 2020. doi:10.1007/s00701-020-04491-7
4. Schwartz A, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme Disease — United States, 2008–2015. MMWR Surveillance Summaries. 2017. doi:10.15585/mmwr.ss6622a1
5. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice Guidelines for the Management of Bacterial Meningitis. Clinical Infectious Diseases. 2004. doi:10.1086/425368
6. Liu X, Li X, Hou Z, et al. Risk Factors for Delayed Facial Palsy Following Microvascular Decompression in Hemifacial Spasm: A Systematic Review and Meta-Analysis.. World neurosurgery. 2025. doi:10.1016/j.wneu.2025.124144